Navigation

WHO pauses hydroxychloroquine trial over safety concerns

WHO pauses hydroxychloroquine trial over safety concerns
The World Health Organization said that it has suspended its trial of the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns.


Share

Post A Comment:

0 comments:

Leave a comment. Thanks!